HomeComparePCCWY vs JNJ

PCCWY vs JNJ: Dividend Comparison 2026

PCCWY yields 6.49% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PCCWY wins by $30.5K in total portfolio value
10 years
PCCWY
PCCWY
● Live price
6.49%
Share price
$7.56
Annual div
$0.49
5Y div CAGR
18.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$60.8K
Annual income
$9,410.47
Full PCCWY calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — PCCWY vs JNJ

📍 PCCWY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPCCWYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PCCWY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PCCWY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PCCWY
Annual income on $10K today (after 15% tax)
$551.54/yr
After 10yr DRIP, annual income (after tax)
$7,998.90/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, PCCWY beats the other by $4,012.91/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PCCWY + JNJ for your $10,000?

PCCWY: 50%JNJ: 50%
100% JNJ50/50100% PCCWY
Portfolio after 10yr
$45.5K
Annual income
$7,049.93/yr
Blended yield
15.48%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PCCWY
No analyst data
Altman Z
1.2
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PCCWY buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPCCWYJNJ
Forward yield6.49%2.13%
Annual dividend / share$0.49$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR18.7%28%
Portfolio after 10y$60.8K$30.3K
Annual income after 10y$9,410.47$4,689.40
Total dividends collected$34.4K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PCCWY vs JNJ ($10,000, DRIP)

YearPCCWY PortfolioPCCWY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,470$770.22$10,592$272.30+$878.00PCCWY
2$13,253$980.06$11,289$357.73+$2.0KPCCWY
3$15,437$1,256.22$12,123$472.89+$3.3KPCCWY
4$18,141$1,623.23$13,141$629.86+$5.0KPCCWY
5$21,527$2,116.12$14,408$846.81+$7.1KPCCWY
6$25,819$2,785.67$16,021$1,151.60+$9.8KPCCWY
7$31,333$3,706.48$18,122$1,588.22+$13.2KPCCWY
8$38,517$4,989.85$20,930$2,228.20+$17.6KPCCWY
9$48,017$6,804.48$24,792$3,191.91+$23.2KPCCWY
10$60,789$9,410.47$30,274$4,689.40+$30.5KPCCWY

PCCWY vs JNJ: Complete Analysis 2026

PCCWYStock

PCCW Limited provides telecommunications and related services in Hong Kong, Mainland and other parts of China, Singapore, and internationally. The company's services include local telephony, local data and broadband, mobile, international telecommunications, and satellite-based and network-based telecommunications services; and outsourcing, consulting, and contact center services. It also provides technical support, electronics and communications engineering, and products and solutions, as well as free television, pay television program, and interactive multimedia services; sells advertising in various telephone directories and on the Internet; publishes directories; and sells mobile handsets and accessories. In addition, the company offers broadcasting and related services, management and engineering support services, customer relationship management and customer contact management solutions, and media content services; and over-the-top video services under the Viu brand, as well as sells customer premises equipment and related solutions. Further, it engages in the sale, distribution, and marketing of telecommunication products and services; supply of broadband internet access solutions and web services; provision of data services; software development, systems integration, consulting, and informatization activities; computer facilities management; the provision of computer and IP/IT related value-added services to business customers; and operates customer loyalty program and online merchandise sales. Additionally, the company offers IT and business process outsourcing, fintech, e-Commerce, big data analytics, managed, digital, cloud, and IoT solutions. PCCW Limited was founded in 1925 and is headquartered in Quarry Bay, Hong Kong.

Full PCCWY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this PCCWY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PCCWY vs SCHDPCCWY vs JEPIPCCWY vs OPCCWY vs KOPCCWY vs MAINPCCWY vs ABBVPCCWY vs MRKPCCWY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.